Zihao Liu

1.8k total citations
49 papers, 1.3k citations indexed

About

Zihao Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zihao Liu has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zihao Liu's work include Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Zihao Liu is often cited by papers focused on Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Zihao Liu collaborates with scholars based in China, United Kingdom and United States. Zihao Liu's co-authors include Chang Gong, Gehao Liang, Luyuan Tan, Erwei Song, Yun Ling, Wenjing Zhong, Weige Tan, You Zhou, Qun Lin and Robert Andrews and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Zihao Liu

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zihao Liu China	15	1.0k	909	91	90	75	49	1.3k
Agnes T. Reiner Austria	12	982 1.0×	764 0.8×	95 1.0×	24 0.3×	44 0.6×	23	1.2k
Piao Huang China	7	542 0.5×	435 0.5×	140 1.5×	38 0.4×	85 1.1×	13	887
Zhixian Jin China	8	1.4k 1.4×	661 0.7×	158 1.7×	194 2.2×	118 1.6×	15	1.6k
Dijie Li China	19	931 0.9×	354 0.4×	101 1.1×	42 0.5×	20 0.3×	37	1.2k
Marika Salmanidis Australia	10	1.9k 1.9×	1.6k 1.7×	68 0.7×	26 0.3×	42 0.6×	10	2.1k
Suxiang Chen Australia	16	1.2k 1.2×	432 0.5×	31 0.3×	24 0.3×	37 0.5×	30	1.4k
Stanislas Werfel Germany	9	1.0k 1.0×	569 0.6×	25 0.3×	41 0.5×	35 0.5×	12	1.2k
Venkatareddy Nadithe United States	8	1.1k 1.1×	536 0.6×	46 0.5×	11 0.1×	84 1.1×	9	1.3k
Omar M. Khan Qatar	14	422 0.4×	199 0.2×	117 1.3×	49 0.5×	33 0.4×	33	729

Countries citing papers authored by Zihao Liu

Since Specialization

Citations

This map shows the geographic impact of Zihao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihao Liu more than expected).

Fields of papers citing papers by Zihao Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihao Liu. The network helps show where Zihao Liu may publish in the future.

Co-authorship network of co-authors of Zihao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zihao Liu. A scholar is included among the top collaborators of Zihao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihao Liu. Zihao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Yuan, Zihao Liu, Jianpeng Yu, et al.. (2025). Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features. Current Urology. 20(1). 1–14.

Liu, Zihao, et al.. (2024). Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study. International Journal of Surgery. 111(1). 857–864. 2 indexed citations

Liu, Zihao, Huan Zhang, Kaili Lu, et al.. (2024). Low-intensity pulsed ultrasound modulates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Cell Reports. 43(9). 114660–114660. 7 indexed citations

Chen, Jiayi, Yingying Zhu, Wei Wu, et al.. (2024). Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study. The Oncologist. 29(7). e864–e876. 3 indexed citations

Fu, Hongliang, Sheng Liang, Miaomiao Xu, et al.. (2023). An ¹⁸F-MD-PSMA (Multi-dentate PMSA Imaging Agent) PET/CT in Prostate Cancer Relapse: Results of a Retrospective Trial. Current Radiopharmaceuticals. 17(4). 382–397.

Amin, Avnika B., Jordan Cates, Zihao Liu, et al.. (2023). Rotavirus Genotypes in the Postvaccine Era: A Systematic Review and Meta-analysis of Global, Regional, and Temporal Trends by Rotavirus Vaccine Introduction. The Journal of Infectious Diseases. 229(5). 1460–1469. 11 indexed citations

Ling, Yun, Gehao Liang, Qun Lin, et al.. (2022). circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer. Molecular Cancer. 21(1). 8–8. 67 indexed citations

Tong, Yong, et al.. (2022). Fabricating multi-porous carbon anode with remarkable initial coulombic efficiency and enhanced rate capability for sodium-ion batteries. Chinese Chemical Letters. 34(1). 107443–107443. 76 indexed citations

Gao, Jie, Zihao Liu, Mengli Huang, et al.. (2021). Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer. Medicine. 100(35). e27130–e27130. 5 indexed citations

10.

Li, Xiaopeng, et al.. (2021). Development of a novel digital integration system for magnetic measurement on HL-2M tokamak. 1848–1853. 1 indexed citations

11.

Gong, Chang, Zihao Liu, Qun Lin, et al.. (2021). Anti-PITPNM3 small molecular compounds reverse breast cancer metastasis by targeting PITPNM3.. Journal of Clinical Oncology. 39(15_suppl). e15005–e15005. 1 indexed citations

12.

Shi, Yu, et al.. (2021). MiRNAs and Cancer: Key Link in Diagnosis and Therapy. Genes. 12(8). 1289–1289. 74 indexed citations

13.

Zhong, Wenjing, Yaping Yang, Ailing Zhang, et al.. (2020). Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer. Breast Cancer. 27(6). 1147–1157. 8 indexed citations

14.

Gong, Chang, Wanyi Lin, Yaping Yang, et al.. (2020). Effect of Low & High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Randomized Clinical Trial. Journal of the American College of Surgeons. 231(4). e83–e84.

15.

Yu, Jianpeng, et al.. (2019). Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma. Annals of Translational Medicine. 7(16). 377–377. 6 indexed citations

16.

Wang, Qian, Han Liu, Zihao Liu, et al.. (2019). Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC. Cancer Genetics. 240. 33–39. 43 indexed citations

17.

Tan, Weige, Gehao Liang, Xinhua Xie, et al.. (2019). Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer. The Oncologist. 24(11). e1044–e1054. 17 indexed citations

18.

Chen, Qingwang, et al.. (2018). Isolation of a feather-degrading strain of bacterium from spider gut and the purification and identification of its three key enzymes. Molecular Biology Reports. 45(6). 1681–1689. 15 indexed citations

19.

Liu, Zihao, Andrew J. Sanders, Gehao Liang, et al.. (2017). Hey Factors at the Crossroad of Tumorigenesis and Clinical Therapeutic Modulation of Hey for Anticancer Treatment. Molecular Cancer Therapeutics. 16(5). 775–786. 14 indexed citations

20.

Xiao, Xi, et al.. (2014). Paper Synthesis, Cytotoxicity and Apoptosis Induction in Human Tumor Cells by Galaxamide and Its Analogues. Marine Drugs. 12(8). 4521–4538. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact